Dr. Athiya Agarwal has reported the acquisition of 14,41,568 shares (0.455% stake) in Dr. Agarwal’s Health Care Limited via an inter-se transfer by way of a gift from Dr. Anosh Agarwal on March 19, 2026. This transaction occurred solely among immediate relatives within the Promoter Group and did not alter the total shareholding percentage of the group. Following the transfer, Dr. Athiya Agarwal’s stake increased to 4.45%, while Dr. Anosh Agarwal’s decreased to 4.23%.
Report on Promoter Group Share Transfer
This disclosure details the acquisition of shares in Dr. Agarwal’s Health Care Limited (the Target Company) by Dr. Athiya Agarwal, who is listed as the Acquirer. The transaction was completed on March 19, 2026, involving an inter-se transfer of shares within the existing Promoter and Promoter Group.
Details of the Acquisition
The acquisition involved 14,41,568 shares, representing 0.455% of the diluted share capital of the Target Company. These shares were acquired from Dr. Anosh Agarwal, the Transferor/Seller.
The rationale for this movement of equity was a transfer by way of “Gift”. This transaction utilized the exemption provided for transfers among immediate relatives. As a direct result of this gift, there was no change in the aggregate Total Shareholding of the Promoter and Promoter Group.
The initial intimation regarding this proposed acquisition was filed on March 6, 2026, adhering to the necessary regulatory timelines.
Shareholding Status Post-Transaction
The report provides a clear breakdown of the shareholding changes among the involved parties:
Acquirer (Dr. Athiya Agarwal)
- Pre-Transaction Holdings: 1,26,61,975 shares (4.00% of TC capital)
- Post-Transaction Holdings: 1,41,03,543 shares (4.45% of TC capital)
Seller (Dr. Anosh Agarwal)
- Pre-Transaction Holdings: 1,48,57,920 shares (4.69% of TC capital)
- Post-Transaction Holdings: 1,34,16,352 shares (4.23% of TC capital)
The transaction involved no monetary consideration as the shares were acquired through a gift between the immediate relatives.
The report is signed by Dr. Athiya Agarwal, Acquirer, on March 23, 2026, from Chennai.
Source: BSE
